These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16219952)

  • 1. Polycystic ovarian syndrome in Hong Kong Chinese women: patient characteristics and diagnostic criteria.
    Lam PM; Ma RC; Cheung LP; Chow CC; Chan JC; Haines CJ
    Hong Kong Med J; 2005 Oct; 11(5):336-41. PubMed ID: 16219952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for dysglycaemia by oral glucose tolerance test should be recommended in all women with polycystic ovary syndrome.
    Li HW; Lam KS; Tam S; Lee VC; Yeung TW; Cheung PT; Yeung WS; Ho PC; Ng EH
    Hum Reprod; 2015 Sep; 30(9):2178-83. PubMed ID: 26202923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher metabolic risk in Chinese women fulfilling the NIH diagnostic criteria for polycystic ovarian syndrome.
    Lam PM; Tam WH; Cheung LP
    Fertil Steril; 2009 Apr; 91(4 Suppl):1493-5. PubMed ID: 18851848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
    Azziz R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of polycystic ovary syndrome].
    Belosi C; Giuliani M; Suriano R; Sagnella F; Lanzone A
    Minerva Ginecol; 2004 Feb; 56(1):7-13. PubMed ID: 14973406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of polycystic ovarian syndrome based on ultrasound findings and clinical parameters.
    Moschos E; Twickler DM
    J Clin Ultrasound; 2015 Mar; 43(3):157-63. PubMed ID: 24898321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
    Shi Y; Gao X; Sun X; Zhang P; Chen Z
    Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
    Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
    Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic criteria in polycystic ovary syndrome.
    Legro RS
    Semin Reprod Med; 2003 Aug; 21(3):267-75. PubMed ID: 14593549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
    Anaforoglu I; Algun E; Incecayir O; Ersoy K
    Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
    Hart R; Hickey M; Franks S
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):671-83. PubMed ID: 15380140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.
    Carmina E; Orio F; Palomba S; Longo RA; Lombardi G; Lobo RA
    Fertil Steril; 2005 Aug; 84(2):413-9. PubMed ID: 16084883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.